haloperidol has been researched along with asimadoline in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
Barber, A; Bartoszyk, GD; Bender, HM; Gottschlich, R; Greiner, HE; Harting, J; Mauler, F; Minck, KO; Murray, RD; Simon, M | 1 |
Barber, A; Bartoszyk, GD; Gottschlich, R; Seyfried, CA | 1 |
3 other study(ies) available for haloperidol and asimadoline
Article | Year |
---|---|
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.
Topics: Acetamides; Adrenergic alpha-Agonists; Analgesics; Animals; Autoradiography; Blood-Brain Barrier; Capillary Permeability; Dihydroxyphenylalanine; Diuresis; Haloperidol; Hexobarbital; Male; Mice; Narcotics; Pain Measurement; Peripheral Nervous System; Postural Balance; Prostaglandin Antagonists; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa | 1994 |
The peripherally acting kappa-opiate agonist EMD 61753 and analogues: opioid activity versus peripheral selectivity.
Topics: Acetamides; Analgesics, Opioid; Animals; Cerebellum; Dopamine Antagonists; Guinea Pigs; Haloperidol; Levodopa; Male; Nucleus Accumbens; Peripheral Nervous System; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa | 1995 |